Wealthcare Advisory Partners LLC Biomarin Pharmaceutical Inc Transaction History

Wealthcare Advisory Partners LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$82.16 - $96.94 $7,147 - $8,433	87 Added 3.04%	2,951 $250,000
Q2 2022 Aug 15, 2022	BUY	$71.48 - $86.85 $204,718 - $248,738	2,864 New	2,864 $237,000
Q2 2021 Aug 16, 2021	SELL	$75.51 - $84.79 $302 - $339	-4 Closed	0 $0
Q1 2021 Apr 30, 2021	BUY	$74.73 - $90.69 $298 - $362	4 New	4 $0
Q2 2020 Jul 29, 2020	SELL	$79.55 - $124.22 $795 - $1,242	-10 Closed	0 $0
Q1 2020 Apr 29, 2020	BUY	$71.37 - $96.85 $713 - $968	10 New	10 $1,000

637

177M

2.01M

1.28M

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $12.5B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

Get notified when there are updates to the investment portfolio of Wealthcare Advisory Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Wealthcare Advisory Partners LLC with notifications on news.